Delivery Order SPE2DB20D1047-SPE2DB25FF76T
- Not listed
- The Defense Logistics Agency awarded a $3,320.62 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Taltz 80 mg/ml autoinjector medication. This is a firm fixed price, competitively awarded contract with performance completion targeted for August 1, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,133.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/mL auto-injector medication, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $4,083.21 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) on July 28, 2025, with completion targeted for July 29, 2025. This non-competitive delivery order utilizes firm fixed-price pricing and is fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a $9,973.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical product, with an ultimate completion date of July 30, 2025. This is a non-set-aside award issued on July 29, 2025, with fulfillment based at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication, valued at $72,800.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract carries an ultimate completion date of August 1, 2025, and performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Taltz 80 mg/ml autoinjectors with a ceiling value of $4,197.10. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, reflecting a short fulfillment timeline for this pharmaceutical product. The contract utilizes no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $11,664.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 31, 2025, with completion due August 1, 2025. This non-set-aside contract represents a small-value pharmaceutical supply delivery executed through AmerisourceBergen's existing federal contract vehicle with DLA. The award leverages the contractor's established relationship with the Defense Logistics Agency Medical Supply Chain, which has...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication with a ceiling value of $3,698.27. This non-set-aside, competitively awarded contract employs firm fixed price pricing and is scheduled for completion by July 31, 2025. The delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF76TDelivery Order
The Defense Logistics Agency awarded a $3,543.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Taltz 80 mg/ml autoinjector, with an ultimate completion date of August 8, 2025. This non-competitive delivery order represents a single pharmaceutical supply transaction executed by the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this delivery order as part of its extensive portfolio supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The autoinjector delivery aligns with the company's demonstrated capability in providing specialized medical supplies and brand-name pharmaceutical products across multiple therapeutic domains. As a competitively positioned prime vendor within DLA's pharmaceutical supply chain, AmerisourceBergen continues to support military medical requirements through flexible contracting vehicles designed to ensure consistent availability of critical healthcare commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/7/25 |